AI assistant
Merck & Co., Inc. — Director's Dealing 2023
May 5, 2023
284_dirs_2023-05-05_edec27ee-6c0d-4cb0-96f5-a1fb476e8fac.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2023-05-03
Reporting Person: Karachun Rita A (Sr. VP Fince-Global Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-05-03 | Common Stock | M | 803 | $117.89 | Acquired | 45362.972 | Direct |
| 2023-05-03 | Common Stock | F | 276 | $117.89 | Disposed | 45086.972 | Direct |
| 2023-05-04 | Common Stock | M | 949 | $118.22 | Acquired | 46035.972 | Direct |
| 2023-05-04 | Common Stock | F | 326 | $118.22 | Disposed | 45709.972 | Direct |
| 2023-05-04 | Common Stock | M | 15875 | $62.07 | Acquired | 61584.972 | Direct |
| 2023-05-04 | Common Stock | S | 15875 | $117.5334 | Disposed | 45709.972 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-05-03 | Restricted Stock Unit | $ | M | 803 | Disposed | 2025-05-03 | Common Stock (803) | Direct |
| 2023-05-04 | Restricted Stock Unit | $ | M | 949 | Disposed | 2024-05-04 | Common Stock (949) | Direct |
| 2023-05-04 | Stock Option (Right to Buy) | $62.07 | M | 15875 | Disposed | 2027-05-04 | Common Stock (15875) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.5000 to $117.6200, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
F2: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F3: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2023, 5/3/2024 and 5/3/2025.
F4: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.
F5: The option became exercisable in equal installments on 5/5/2018, 5/5/2019 and 5/5/2020.